Skip to main content

Frito-Lay Recalls Lay's Chips Due to Milk Allergy Concerns

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 22, 2024.

By Physician’s Briefing Staff HealthDay Reporter

FRIDAY, Dec. 20, 2024 -- Frito-Lay has recalled select 13-oz bags of Lay's Classic Potato Chips due to undeclared milk, which could pose a serious risk to those with milk allergies.

According to a report released by the U.S. Food and Drug Administration, the affected bags have a "guaranteed fresh" date of Feb. 11, 2025, and the manufacturing codes 6462307xx or 6463307xx.

These chips were distributed in Oregon and Washington through retail stores and online distributors, the media report said. Consumers may have purchased them starting in early November. Frito-Lay clarified that no other Lay's products or sizes are impacted by the recall.

While no illnesses or adverse reactions have been reported so far, individuals with allergies or severe sensitivities to milk are advised to avoid consuming the chips and discard them immediately.

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Antibiotic Exposure Before Age 2 May Increase Risk for Chronic Pediatric Conditions

WEDNESDAY, April 30, 2025 -- Children receiving multiple antibiotic courses between birth and age 2 years may have a higher risk for some chronic conditions, according to a study...

Climate Change Tied to Alterations in Pollen Seasons, Concentrations

FRIDAY, April 11, 2025 -- Climate change seems to be altering pollen seasons and concentrations, potentially impacting allergic rhinitis, according to a review published online...

American Academy of Allergy, Asthma & Immunology, Feb. 28-March 3

The annual meeting of the American Academy of Allergy, Asthma & Immunology was held from Feb. 28 to March 3 in San Diego, drawing clinicians, academicians, allied...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.